Doxazosin Tablet
Product Images NDC 71610-927

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71610-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0927 53)

Label (71610 0927 53)
Doxazosin 4 mg oral tablets packaging label showing a bottle containing 60 tablets. The label includes storage instructions to keep between 20-25°C, dispense in a light-resistant container, and keep out of reach of children. It lists the manufacturer as Greentree LLC with repackaging by Aphena Pharma, Cookeville, TN. The label also features the NDC number 71610-927-53 and states RX only.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Doxazosin 01)

Chemical Structure (Doxazosin 01)
Chemical structure diagram of doxazosin mesylate, the active ingredient in Doxazosin 4 mg oral tablets by Aphena Pharma Solutions - Tennessee, LLC.*
FDA Label Image

Table 3 (Doxazosin 02)

Table 3 (Doxazosin 02)
A bar chart and data table summarizing effectiveness data from placebo-controlled trials for doxazosin (Cardura) tablets. The data show symptom score changes and maximum flow rate in three studies with varying doses up to 8 mg. The chart highlights significant improvements in maximum flow rate and symptom scores at 4 mg and 8 mg doses compared to placebo.*
FDA Label Image

Figure 1 (Doxazosin 03)

Figure 1 (Doxazosin 03)
Two line graphs display clinical data on doxazosin treatment effects over 14 weeks. The left graph shows mean change in total symptom score from baseline, comparing CARDURA and placebo groups. The right graph depicts mean increase in maximum urinary flow rate from baseline for CARDURA versus placebo over the same period. Sample sizes are noted for each group.*
FDA Label Image

Logo (Doxazosin 04)

Logo (Doxazosin 04)
Label for Greenstone Brand drug distributed by Greenstone LLC, Peapack, NJ 07977. The image displays distribution information with the Greenstone logo and distributor address but does not specify the drug name, strength, or dosage form.*
FDA Label Image

Logo (Doxazosin 04a)

Logo (Doxazosin 04a)
Label panel displaying Greenstone® Brand distributed by Greenstone LLC, Peapack, NJ 07977. No specific drug name, strength, dosage form, or other product details are shown in this image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.